The fastest way to understand why RA exists is to show you what happens without it.

Here are 4 major brands that learned the hard way - with FDA warning letters, lawsuits, and settlements in the hundreds of millions.

🍊Poppi marketed their soda with slogans like "Be Gut Happy" and "Be Gut Healthy," implying significant digestive benefits from their prebiotic ingredient (agave inulin). Class-action lawsuit argues each can contains less than 2 grams of prebiotic fiber, far below the 5-7.5 grams clinically shown to provide gut health benefits. Meanwhile, each can has 5 grams of sugar, which can actually harm gut bacteria.The lawsuit alleges consumers were misled into thinking they were drinking a functional health beverage when they were mostly just drinking... flavored sugar water with a sprinkle of inulin.

🩸Theranos claimed their device could run 200+ blood tests from a single finger prick. Reality: the technology didn't work, tests were unreliable, and they were running patient samples on commercial analyzers while pretending it was their own tech. FDA inspections found major deficiencies. CMS (Centers for Medicare & Medicaid Services) revoked their lab certification.

🍫 KIND Snacks labeled their bars as "healthy" and "+antioxidant" when the bars exceeded FDA limits for fat content (to be called "healthy") and didn't meet requirements for antioxidant claims. The FDA sent a warning letter saying the labels were in violation of federal food labeling regulations.

🚬 JUUL marketed to teens with flavors like "Mango" and "Crème Brûlée." Also made claims that their product was safer than cigarettes, without FDA authorization to make reduced-risk claims. FDA cracked down. Multiple states sued for targeting minors.

A weekly roundup of the digital apps and platforms that don’t..well..suck.

💉 The Next-Gen Weight Loss Peptide A buzzy new “triple agonist” peptide, retatrutide, is emerging as the next‑gen weight-loss drug after semaglutide and tirzepatide, by acting on GLP‑1, GIP, and glucagon pathways at once. Despite influencer and “fitness bro” hype, experts stress that retatrutide is a potent prescription medication, not a casual peptide shot, and will require careful medical supervision if and when it’s approved.

🧬 FDA Approves New Treatment for Pancreatic Cancer FDA greenlights Optune Pax, a wearable "tumor-zapping" vest, for locally advanced pancreatic cancer, the first fresh option in 30 years! Paired with chemo, it boosts survival from 14 to 16 months, delays pain by 6 months, with just mild skin itch as the main side effect.​ Patients can wear it 24/7 while living life, expect insurance coverage soon!

Coming up: how to break into RA (featuring Regulatory Affairs professional that has a decade-worth of experience and tips to share), job listings, and more tea on clinical research, health, wellness and tech.

Something to ask yourself:

"Why do we trust labels we've never actually read?"

Think about it. You're standing in the supplement aisle at Target. You pick up a bottle that says "Supports Immune Health" and just believe it.

You don't read the ingredient list. You don't check if there's a study backing the claim. You don't verify if the active ingredients are even dosed at levels that do anything.

You just trust the label because it's printed on a bottle.

We've outsourced our critical thinking to packaging design. A clean label with sans-serif fonts and a leaf logo = must be legit. A bottle that says "clinically tested" without citing the test = close enough.

Here's the thing: brands know this. They know you won't read the fine print. They know you'll scan the front label, see "natural" and "science-backed," and move on with your life.

Let 2026 be the year of vigilance and staying on top of our health.

Welcome home. See you in the next issue. 🖤